REsponsible roLl-out of E-heAlth Through Systematic Evaluation - Heart Failure Study

Telemedicine is gradually becoming accepted in heart failure (HF) management. Meta-analyses show a positive effect of telemedicine on hospital admission, length of stay, mortality, and costs. However, the magnitude of the effect is heterogeneous because of the variety in the HF population using telemedicine, components of telemedicine, and variety in considered costs. Despite the lack of clear guidance how to implement telemedicine within routine HF management, implementation of telemedicine is advocated by payers, private companies, and patient organizations.In this nationwide study the investigators aim to identify in which subgroup of HF patients telemedicine is (cost-)effective, and which intervention components of telemedicine are most (cost-)effective.

Inclusion Criteria:All heart failure patients newly admitted to a hospital outpatient clinic for HFAll phenotypes of heart failure that meet the ESC 2021 guidelinePatient who has been diagnosed with heart failure in a setting other than the one where the patient currently presents (primary, secondary or tertiary care)